Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Dividends and bonus issues: 31 stocks turning ex-record date this week. Do you own any?
As many as 31 companies, including HDFC Bank, Tata group firms and Brigade Enterprises, will turn ex-record date for dividends and bonus issues between June 15 and June 19. The list spans financials, industrials and healthcare, offering investors multiple opportunities to track payouts and corporate actions during the week.
Further consolidation ahead for Nifty? Here's today's outlook and top picks
Ajit Mishra of Religare Broking has recommended buying the shares of Fortis Healthcare, RBL Bank, and Eternal today
Sensex Today | Stock Market LIVE Updates: GIFT Nifty trades lower; Jefferies initiates 'buy' for Meesho
Sensex Today | Stock Market LIVE Updates: The Nifty though, dragged by HDFC Bank and IT on Tuesday, would be hopeful that both put their hand up and enable a breakout for the index as well. A factor that bulls will take heart from is that Reliance Industries snapped a nine-day losing streak on Tuesday and if that rebounds from lower levels, it will be a big boost to the index.
Trading guide: Check key Nifty levels to watch; two stocks to buy today
Vinay Rajani of HDFC Securities suggests Nifty trading strategy and suggests buying Bank of Maharashtra, and Viyash Scientific; here's why
Bombay HC rejects Lilavati Trust's defamation plea, says HDFC Bank's claims were truthful
The Bombay High Court on Tuesday dismissed an interim application filed by the Lilavati Kirtilal Mehta Medical Trust, which runs Mumbai's Lilavati Hospital, seeking to restrain HDFC Bank, its Managing Director and CEO Sashidhar Jagdishan, and others from making allegedly defamatory statements against the Trust and its members.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
Vinay Rajani of HDFC Sec suggests Viyash Scientific, Federal Bank shares to buy in near-term - Mint
Vinay Rajani of HDFC Sec suggests Viyash Scientific, Federal Bank shares to buy in near-termMint
7 most valued firms' mcap eroded ₹1.25 trn last week, RIL took biggest hit
The combined market valuation of seven of the top-10 most-valued firms eroded by Rs 1.25 lakh crore last week, with Reliance Industries taking the biggest hit, in-line with a bearish trend in equities. Last week, the BSE benchmark Sensex declined 532.4 points, or 0.71 per cent, and the NSE Nifty dipped 181.05 points, or 0.76 per cent. "Persistent FII selling remained the key drag on market sentiment despite supportive developments such as cooling crude oil prices and a recovery in the rupee against the US dollar. Concerns regarding the pace of monsoon advancement also weighed on investor confidence," Santosh Meena, Head of Research at Swastika Investmart Ltd, said. From the top-10 pack, Reliance Industries, Bharti Airtel, Tata Consultancy Services (TCS), Bajaj Finance, Larsen & Toubro, Life Insurance Corporation of India (LIC) and Hindustan Unilever faced erosion from their valuation, while HDFC Bank, ICICI Bank, and State Bank of India were the gainers. The market valuation of ...